Skip to main content
SpringerLink
Log in

Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The relevance of the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds to the clinical therapeutics of acute myocardial infarction was evaluated in 20 patients with an uncomplicated acute myocardial infarction by comparing the haemodynamic effects of equivalent beta-blocking doses of propranolol (non-cardioselective; no ISA) and pindolol (non-cardioselective; 50% ISA). Consecutive eligible male patients admitted to a Coronary Care Unit were randomised following a 1 h control period to two separate studies. In Study 1 the short-term dose-response effects of propranolol (1–8 mg) or pindolol (0.1–0.8 mg) were assessed. In Study 2 comparison of the effects of single i.v. propranolol (8 mg) and pindolol (0.8 mg) doses was undertaken over 6 h. Haemodynamic variables and thermodilution cardiac output were subsequently recorded to compare the effects of each drug on the circulation. The plasma concentrations of propranolol and pindolol were in the recognised therapeutic range. Both drugs were clinically well-tolerated, the changes induced in haemodynamic variables following each drug demonstrated effective beta-blockade. Within the limits of the experimental protocol, these data did not suggest definite haemodynamic advantage for ISA of pindolol in acute myocardial infarction. These findings are perhaps due to sympathetic activation in acute myocardial infarction attenuating the haemodynamic impact of ISA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sonnenblick EH, Ross J, Covell JW, Kaiser GA, Braunwald E (1965) Velocity of contraction as a determinant of myocardial oxygen consumption. Am J Physiol 209: 919–927

    Google Scholar 

  2. Braunwald E (1969) Thirteenth Bowditch Lecture. The determinants of myocardial oxygen consumption. Physiologist 12: 65–93

    Google Scholar 

  3. Opie LH, Thomas M (1976) Propranolol and experimental myocardial infarction. Postgrad Med J 52 [Suppl 4]: 124–134

    Google Scholar 

  4. Taylor SH, Burley D (1977) Beta-adrenoceptor drugs in post-myocardial infarction dysrhythmias. Proc Roy Soc Med 70 [Suppl 11]: 11–16

    Google Scholar 

  5. Singh BN and Jewett DE (1974) Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs 7: 426–461

    Google Scholar 

  6. Maroko PR, Kjekshus JK, Sobel BE et al. (1971) Factors influencing infarct size following experimental coronary artery occlusion. Circulation 43: 67–82

    Google Scholar 

  7. Norris RM, Clarke ED, Sammel NL, Smith WM, Williams B (1978) Protective effect of propranolol in threatened myocardial infarction. Lancet 2: 907–909

    Google Scholar 

  8. Pelides LJ, Reid DW, Thomas M, Shillingford JP (1972) Inhibition by beta-blockade of the ST segment elevation after acute myocardial infarction in man. Cardiovasc Res 6: 295–302

    Google Scholar 

  9. Reid DS, Pelides LJ, Shillingford JP, Thomas M (1976) Electrocardiographic surface mapping of the heart following myocardial infarction and the influence of beta-blockade. Postgrad Med J 52 [Suppl 4]: 135–139

    Google Scholar 

  10. Peter T, Norris RM, Clarke ED et al. (1978) Reduction of enzyme level by propranolol after acute myocardial infarction. Circulation 57: 1091–1095

    Google Scholar 

  11. Ramsdale D, Farragher BE, Ward C et al. (1982) Pain relief in acute myocardial infarction by intravenous atenolol. Am Heart J 103: 459–467

    Google Scholar 

  12. Svendsen TL, Hartling O, Trap-Jensen J (1979) Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89406 in healthy volunteers. Eur J Clin Pharmacol 15: 223–228

    Google Scholar 

  13. Svendsen T, Hartling OJ, Trap-Jensen J, McNair A, Bliddal J (1981) Adrenergic beta-receptor blockade: haemodynamic importance of intrinsic sympathomimetic activity. Clin Pharmacol Ther 29: 711–718

    Google Scholar 

  14. Taylor SH, Silke B, Lee PS (1981) Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity haemodynamically useful? N Engl J Med 306: 631–635

    Google Scholar 

  15. Taylor SH, Silke B, Lee PS, Hilail A (1982) Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease. Eur Heart J 3: 564–569

    Google Scholar 

  16. Karlsberg RP, Penkoske PA, Cryer PE, Corr PB, Roberts R (1979) Rapid activation of the sympathetic system following coronary artery occlusion: relation to infarct size, site and haemodynamic impact. Cardiovasc Res 13: 523–531

    Google Scholar 

  17. Valori C, Thomas M, Shillingford J (1967) Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. Am J Cardiol 20: 605–617

    Google Scholar 

  18. Kostuk W, Barr JW, Simon AL, Ross J (1973) Correlations between the chest film and haemodynamics in acute myocardial infarction. Circulation 48: 624–632

    Google Scholar 

  19. Carruthers SG (1982) Cardiac dose-response relationships of oral and intravenous pindolol. Br J Clin Pharmacol 13: 193S-198S

    Google Scholar 

  20. Dixon WJ, Brown MB (1979) Biomedical computer program — ‘P’ Series. University of California Press, Berkeley, pp 540–580

    Google Scholar 

  21. Winer BJ (1971) Statistical principles in experimental design (2nd edn). McGraw-Hill, New York, pp 197–200

    Google Scholar 

  22. Rose GA, Blackburn H (1968) Cardiovascular survey methods. WHO Monograph Series 56: 137–174

    Google Scholar 

  23. Lochan R, Silke B, Taylor SH (1981) Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous injection in man. Br J Clin Pharmacol 12: 721–724

    Google Scholar 

  24. Verma SP, Nelson GIC, Silke B, Hussain M, Taylor SH (1983) Are there any advantages of intravenous over oral beta-adrenoceptor blockade immediately following acute myocardial infarction (AMI). Clin Sci 65: 34p

  25. Seino Y, Takano T, Tanaka K, Hayakawa H (1983) Peripheral circulatory adjustments and the vasodilator intervention in acute myocardial infarction. Abstracts VIII As-Pac Congr Cardiol, A-570

  26. Ablad B, Carlsson E, Ek L, Johnsson G, Lundgren B (1979) General pharmacology of beta-adrenoceptor antagonists. In: Poppers PJ (ed) Beta-blockade and general anaesthesia. Astra Pharmaceuticals, Rijwijk, pp 46–58

    Google Scholar 

  27. Clark BJ, Menninger K, Bertholet A (1982) Pindolol — the pharmacology of a partial agonist. Br J Clin Pharmacol 13: 149S-158S

    Google Scholar 

  28. Silke B, Nelson GIC, Ahuja RC, Okoli RC, Taylor SH (1983) Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease. Eur J Clin Pharmacol 25: 157–165

    Google Scholar 

  29. Silke B, Nelson GIC, Ahuja RC, Taylor SH (1982) Comparative haemodynamic dose-response effects of propranolol and labetalol in coronary heart disease. Br Heart J 48: 364–371

    Google Scholar 

  30. Nelson GIC, Ahuja RC, Hussain M, Silke B, Taylor SH (1983) Alpha- and beta-blockade with labetalol in acute myocardial infarction. J Cardiovasc Pharmacol 4: 921–924

    Google Scholar 

  31. Silke B, Nelson GIC, Ahuja RC, Choudhury S, Taylor SH (1983) Pharmacokinetic and haemodynamic studies with labetalol in acute myocardial infarction. Ir J Med Sci 152: 179–186

    Google Scholar 

  32. Silke B, Nelson GIC, Verma SP, Hussain M, Walker C, Taylor SH (1984) Enhanced haemodynamic effects of propranolol in acute myocardial infarction. Eur Heart J 5: 366–373

    Google Scholar 

  33. Mueller H, Ayres SM (1976) Propranolol in acute myocardial infarction in man: effects on haemodynamics and myocardial oxygenation. Postgrad Med J 52 [Suppl 4]: 141–148

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Department of Cardiovascular Studies and Department of Medical Cardiology, The General Infirmary, Leeds, England

    B. Silke, S. P. Verma, R. C. Ahuja, M. Hussain, M. Hafizullah, G. Reynolds, G. I. C. Nelson & S. H. Taylor

Authors
  1. B. Silke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. P. Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. C. Ahuja
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Hafizullah
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. I. C. Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. H. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silke, B., Verma, S.P., Ahuja, R.C. et al. Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?. Eur J Clin Pharmacol 27, 509–515 (1984). https://doi.org/10.1007/BF00556884

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00556884

Key words

Search

Navigation